Mode
Text Size
Log in / Sign up
N/A N=26 Randomized Treatment

Feasibility Study to Evaluate a New Energy Storage and Return Prosthetic Foot

Lower Limb Amputation Below Knee (Injury) · Lower Limb Amputation Above Knee (Injury) · Lower Limb Amputation Knee

Enrolled (actual)
26
Serious AEs
5.6%
Results posted
Sep 2024
Primary outcome: Primary: Patient-perceived Mobility (PLUS-M)™ — 57.2; 56.9; 58.3; 57.6 units on a scale — p=0.286

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Revo-M (Device); Taleo (Device); Proflex XC (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Otto Bock Healthcare Products GmbH
Primary completion
Mar 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Patient-perceived Mobility (PLUS-M)™
57.2; 56.9; 58.3; 57.6 0.286
PRIMARY
Patient-perceived Activity Restrictions (Revised TAPES-AR Subscale)
0.653; 0.686; 0.569; 0.674 0.031 sig
SECONDARY
Percentage of Subjects Showing Improvement in Walking Endurance or Perceived Exertion in the 6-minute Walk Test
11; 8; 10
SECONDARY
Patient Perceived Balance Confidence (ABC)
86.8; 86.2; 87.7; 86.9 0.421
SECONDARY
Functional Satisfaction With Prosthesis (TAPES-FUN)
21.6; 21.5; 22.1; 20.4 0.443

Summary

A prospective, interventional, multicenter pilot study to characterize differences in performance and patient reported outcomes between the Taleo, Proflex XC, and the new Revo prosthetic foot.

Eligibility Criteria

Inclusion Criteria

  • Person is 18 years or older.
  • Currently uses an energy storage and return foot.
  • Person has been a unilateral transfemoral (TF), or transtibial (TT) amputee using a prosthesis for at least 1 year.
  • For TF amputees, the person must be wearing an Ottobock Microprocessor-controlled Knee (MPK) with a compatible prosthetic foot
  • Person weighs ≤ 275 lbs (125 kg) size 26-27cm or ≤ 220 lbs (100 kg) size 24-25cm
  • Person is a K3 ambulator based on Medicare Functional Classification Level (MFCL).
  • Prosthetic foot size is 24 to 27 centimeters.
  • Socket Comfort Score of at least 7
  • Ability to read and understand English
  • A person is able and willing to give consent

Exclusion Criteria

  • Current prosthetic foot is too old or worn out as assessed by the CPO.
  • TT subject with currently fit with a Proflex XC or TF subject currently fit with a Taleo.
  • Patient is pregnant or planning to become pregnant.
  • Person who has a life-threatening medical condition (i.e. terminal cancer, severe heart disease).
  • Person has conditions that would prevent participation and pose increased risk (e.g. unstable cardiovascular conditions that preclude physical activity such as walking, problems with vestibular system, etc.).
  • Ulceration or skin breakdown of the residual limb.
  • Person currently has residual limb issues that significantly reduce their ability to load the prosthesis.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04239222). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search